🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

1️⃣10-y #FASTFORWARD early-stage breast 2️⃣ #SKAGEN 50Gy/25 vs 40Gy/15 loco-regional RT high-risk breast 3️⃣10-y ultra #HYPO RT localised prostate 👉In the two most common settings standard RT moved or is moving to hypo-RT instead of conv-RT! Phase 3 trials pratic change 👌

👉Localised setting 1️⃣ #POPART trial:predictors toxicity & oncological outcomes salvage #SAbR prostate bed 👉#oligo-R hormone-sensitive 2️⃣ #PERSIAN trial:ADT-APA 🆚 ADT-APA ➕ #SAbR 3️⃣ substudy #RADIOSA trial:liquid biopsy molecular characterization Great session #GU #ESTRO25

Drew Moghanaki C. Jillian Tsai, MD, PhD Gerry Hanna Percy Lee MD 📢 We'd be the proudest and happiest of all!!! #STARTNEWERA phase II trial is giving us huge satisfaction 💪 ✅ Fast and effectiveness! We believe that #SAbR is the key to to tackling LA-NSCLC 😉 Paola Anselmo Gustavo Jeff Ryckman

C. Jillian Tsai, MD, PhD Jeff Ryckman C. Jillian Tsai, MD, PhD it's great to have your like of our trial!👉doi.org/10.1016/j.ijro… 🤞 Coming soon the updated publication with protocol attached!!! Paola Anselmo Gustavo

ENRT vs. MDT in Prostate Cancer: Promising Results from PEACE V–STORM Trial!!! 🚨OncoAlert 🎯 Objective: Assess if ENRT is superior to MDT for PET-detected pelvic nodal oligorecurrences in prostate cancer 🏥 Methods: • Ph2, RCT, 196 👥, 21 centers • Eligibility: ≥18 y/o,

Fabio Arcidiacono Jeff Ryckman Paola Anselmo Gustavo Can't wait to see the results!

C. Jillian Tsai, MD, PhD Jeff Ryckman Paola Anselmo Gustavo C. Jillian Tsai, MD, PhD you'll be updated right away! It's a promise!!! 😉 And hopefully as soon as possible! 🤞